verapamil has been researched along with pentetic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cohen, S; Krevsky, B; Maurer, AH; Niewiarowski, T | 1 |
| Browning, JD; O'Dell, BL | 1 |
1 review(s) available for verapamil and pentetic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for verapamil and pentetic acid
| Article | Year |
|---|---|
Effect of verapamil on human intestinal transit.
Topics: Adult; Colon; Constipation; Double-Blind Method; Drug Evaluation; Gastrointestinal Transit; Humans; Indium Radioisotopes; Male; Pentetic Acid; Prospective Studies; Verapamil | 1992 |
1 other study(ies) available for verapamil and pentetic acid
| Article | Year |
|---|---|
Zinc deprivation impairs growth factor-stimulated calcium influx into murine 3T3 cells associated with decreased cell proliferation.
Topics: Animals; Becaplermin; Calcium Channel Blockers; Calcium Signaling; Cell Proliferation; Chelating Agents; Epidermal Growth Factor; Growth Substances; Insulin-Like Growth Factor I; Mice; Pentetic Acid; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Recombinant Proteins; Swiss 3T3 Cells; Verapamil; Zinc | 2011 |